Novartis Pharmaceuticals Corporation

Form 483

Vacaville, California, United StatesFEI 3000215618Issued February 05, 2009

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3000215618.

Observations4

Issue DateFebruary 05, 2009

StatusNo Warning Letter

Related Inspections7

Establishment Details

Firm: Novartis Pharmaceuticals Corporation
Location: Vacaville, California, United States
FEI Number: 3000215618
Product Type: Drugs
Issue Date: February 05, 2009
Country: United States

Inspection History, 2009 to 2012

NAI4

VAI3

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Novartis Pharmaceuticals Corporation FDA Form 483, Vacaville, California, February 5, 2009